Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Full Moon BioSystems is a private life science tools company focused on proteomic research products and related assay services. The company develops and markets antibody microarrays for protein expression and phosphorylation profiling, along with monoclonal antibodies, reagent kits, nanobead products, and scanner calibration and validation tools. Its arrays are used for cell signaling studies, biomarker discovery, cytokine profiling, and other translational and basic research applications. Full Moon BioSystems also provides fee-for-service offerings including antibody array assay services, array scanning and image analysis, custom microarray printing, and custom assay development. The business appears to operate as a commercial research tools supplier rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Full Moon BioSystems.